What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

European Psychiatry

Volumn 30, Issue 1, 2015, Pages 43-50

  Schennach, R ^a   Riedel, M ^a,o   Obermeier, M ^a   Seemuller F ^a   Jager M ^a   Schmauss, M ^b   Laux, G ^c   Pfeiffer, H ^d   Naber, D ^e   Schmidt, L G ^f   Gaebel, W ^g   Klosterkotter J ^h   Heuser, I ⁱ   Maier, W ^j   Lemke, M R ^k   Ruther E ^l   Klingberg, S ^m   Gastpar, M ⁿ   Moller H J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b District Hospital Augsburg   (Germany)

^c Inn Salzach Hospital   (Germany)

^d KLINIKUM MÜNCHEN OST   (Germany)

^e UNIVERSITY OF HAMBURG   (Germany)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g Department of Orthopedic Surgery   (Germany)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j UNIVERSITY OF BONN   (Germany)

^k Department of Psychiatry Alsterdorf Hospital ^*  (Germany)

^l UNIVERSITY OF GÖTTINGEN   (Germany)

^m UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

ⁿ UNIVERSITY OF DUISBURG ESSEN   (Germany)

^o Vinzenz von Paul Hospital   (Germany)

more..

Author keywords

CDSS; Correlation analysis; Depressive symptoms; Factor analysis; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; TRANQUILIZER;

ADULT; ARTICLE; CALGARY DEPRESSION SCALE; DEPRESSION; FACTORIAL ANALYSIS; FEMALE; GUILT; HOPELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MOOD DISORDER; MULTICENTER STUDY; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; SCHIZOPHRENIA; SUICIDE; SYMPTOM ASSESSMENT; ACUTE DISEASE; AFFECT; CLINICAL TRIAL; FACTOR ANALYSIS; GERMANY; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; PREVALENCE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

ACUTE DISEASE; ADULT; AFFECT; DEPRESSION; FACTOR ANALYSIS, STATISTICAL; FEMALE; GERMANY; GUILT; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RESEARCH DESIGN; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 84921028185     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2014.11.001     Document Type: Article

References (45)

1. Addington D., Addington J., Schissel B. A depression rating scale for schizophrenics. Schizophr Res 1990, 3:247-251.
2. Addington D., Addington J., Maticka-Tyndale E., Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res 1992, 6:201-208.
3. Addington D., Addington J., Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry 1993, 22:39-44.
4. Addington D., Addington J., Maticka-Tyndale E. Specificity of the Calgary Depression Scale for schizophrenics. Schizophr Res 1994, 11:239-244.
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington DC. Fourth edition.
6. an der Heiden W., Konnecke R., Maurer K., Ropeter D., Hafner H. Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2005, 255:174-184.
7. Badcock J.C., Paulik G., Maybery M.T. The role of emotion regulation in auditory hallucinations. Psychiatry Res 2011, 185:303-308.
8. Bartholomew D.J., Steele F., Galbraith J.I., Moustaki I. The Analysis and Interpretation of Multivariate Data for Social Scientists 2002.
9. Chemerinski E., Bowie C., Anderson H., Harvey P.D. Depression in schizophrenia: methodological artifact or distinct feature of the illness?. J Neuropsychiatry Clin Neurosci 2008, 20:431-440.
10. Collins A.A., Remington G., Coulter K., Birkett K. Depression in schizophrenia: a comparison of three measures. Schizophr Res 1996, 20:205-209.
11. Conley R.R., Scher-Svanum H., Zhu B., Faries D.E., Kinon B.J. The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophr Res 2007, 90:186-197.
12. Cuthbert B.N. The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 2014, 13:28-35. [Epub ahead of print].
13. Hagele C., Schlagenhauf F., Rapp M., Sterzer P., Beck A., Bermpohl F., et al. Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders. Psychopharmacology (Berl) 2014.
14. Hausmann A., Fleischhacker W.W. Differential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a review. Acta Psychiatr Scand 2002, 106:83-96.
15. Hayashi N., Igarashi Y., Yamashina M., Suda K. Is there a gender difference in a factorial structure of the positive and negative syndrome scale? A test by structural equation modeling. Psychopathology 2002, 35:28-35.
16. Insel T., Cuthbert B., Garvey M., Heinssen R., Pine D.S., Quinn K., et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010, 167:748-751.
17. Jager M., Riedel M., Messer T., Laux G., Pfeiffer H., Naber D., et al. Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders. Eur Arch Psychiatry Clin Neurosci 2007, 257:47-53.
18. Jin H., Zisook S., Palmer B.W., Patterson T.L., Heaton R.K., Jeste D.V. Association of depressive symptoms with worse functioning in schizophrenia: a study in older outpatients. J Clin Psychiatry 2001, 62:797-803.
19. Kay S.R., Opler L.A., Lindenmayer J.P. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 1988, 23:99-110.
20. Kitamura T., Suga R. Depressive and negative symptoms in major psychiatric disorders. Compr Psychiatry 1991, 32:88-94.
21. Kontaxakis V.P., Havaki-Kontaxaki B.J., Stamouli S.S., Margariti M.M., Collias C.T., Christodoulou G.N. Comparison of four scales measuring depression in schizophrenic inpatients. Eur Psychiatry 2000, 15:274-277.
22. Kulhara P., Avasthi A., Chadda R., Chandiramani K., Mattoo S.K., Kota S.K., et al. Negative and depressive symptoms in schizophrenia. Br J Psychiatry 1989, 154:207-211.
23. Lake C.R. Hypothesis: grandiosity and guilt cause paranoia; paranoid schizophrenia is a psychotic mood disorder; a review. Schizophr Bull 2008, 34:1151-1162.
24. Lindenmayer J.P., Grochowski S., Kay S.R. Schizophrenic patients with depression: psychopathological profiles and relationship with negative symptoms. Compr Psychiatry 1991, 32:528-533.
25. Linscott R.J., Allardyce J., Van O.J. Seeking verisimilitude in a class: a systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic. Schizophr Bull 2010, 36:811-829.
26. Maggini C., Raballo A. Exploring depression in schizophrenia. Eur Psychiatry 2006, 21:227-232.
27. Majadas S., Olivares J., Galan J., Diez T. Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia. Compr Psychiatry 2012, 53(2):145-151.
28. Moller H.-J. Drug treatment of depressive symptoms in schizophrenia. Clin Schizophr Relat Psychoses 2008, 1:328-340.
29. Muller M.J., Szegedi A., Wetzel H., Benkert O. Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression. Schizophr Bull 2001, 27:19-28.
30. Norman R.M., Malla A.K. Correlations over time between dysphoric mood and symptomatology in schizophrenia. Compr Psychiatry 1994, 35:34-38.
31. R Development Core Team A language and environment for statistical computing 2008, Foundation for Statistical Computing, Vienna, Austria, http://www.R-project.org. Ref Type: Computer Program.
32. Resnick S.G., Rosenheck R.A., Lehman A.F. An exploratory analysis of correlates of recovery. Psychiatr Serv 2004, 55:540-547.
33. Rocca P., Bellino S., Calvarese P., Marchiaro L., Patria L., Rasetti R., et al. Depressive and negative symptoms in schizophrenia: different effects on clinical features. Compr Psychiatry 2005, 46:304-310.
34. Sax K.W., Strakowski S.M., Keck P.E., Upadhyaya V.H., West S.A., McElroy S.L. Relationships among negative, positive, and depressive symptoms in schizophrenia and psychotic depression. Br J Psychiatry 1996, 168:68-71.
35. Seemuller F., Riedel M., Wickelmaier F., Adli M., Mundt C., Marneros A., et al. Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity. J Affect Disord 2008, 108:271-278.
36. Serper M., Berenbaum H. The relation between emotional awareness and hallucinations and delusions in acute psychiatric inpatients. Schizophr Res 2008, 101:195-200.
37. Siris S.G. Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents. Am J Psychiatry 2000, 157:1379-1389.
38. Smith B., Fowler D.G., Freeman D., Bebbington P., Bashforth H., Garety P., et al. Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations. Schizophr Res 2006, 86:181-188.
39. Tapp A., Kilzieh N., Wood A.E., Raskind M., Tandon R. Depression in patients with schizophrenia during an acute psychotic episode. Compr Psychiatry 2001, 42:314-318.
40. Tollefson G.D., Andersen S.W. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?. J Clin Psychiatry 1999, 60(Suppl. 5):23-29. [discussion 30].
41. Van Os J., Kapur S. Schizophrenia. Lancet 2009, 374:635-645.
42. Whiteford H.A., Riney S.J., Csernansky J.G. Distinguishing depressive and negative symptoms in chronic schizophrenia. Psychopathology 1987, 20:234-236.
43. Wolwer W., Buchkremer G., Hafner H., Klosterkotter J., Maier W., Moller H.J., et al. German research network on schizophrenia-bridging the gap between research and care. Eur Arch Psychiatry Clin Neurosci 2003, 253:321-329.
44. Zisook S., Nyer M., Kasckow J., Golshan S., Lehman D., Montross L. Depressive symptom patterns in patients with chronic schizophrenia and subsyndromal depression. Schizophr Res 2006, 86:226-233.
45. Zisook S., Kasckow J.W., Golshan S., Fellows I., Solorzano E., Lehman D., et al. Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial. J Clin Psychiatry 2009, 70:562-571.